Your browser doesn't support javascript.
loading
The relationships of PSA, FPSAR, clinical and pathological stage in patients with prostate cancer / 中华男科学杂志
National Journal of Andrology ; (12): 261-263, 2002.
Artículo en Chino | WPRIM | ID: wpr-322598
ABSTRACT
<p><b>OBJECTIVES</b>To investigate the relationship between clinical and pathological stage, serum prostate specific antigen (PSA) concentration and free-to-total PSA ratio (FPSAR) in patients with prostate cancer.</p><p><b>METHODS</b>Clinical and pathological stage were determined on the basis of pathological examination and clinic material in 42 prostate cancer patients treated by prostatectomy. PSA and FPSAR were measured before the operation. Spearman rank correlation was applied to evaluate the relationship between clinical and pathological stage, serum PSA concentration and FPSAR.</p><p><b>RESULTS</b>Serum PSA concentration was significantly positively correlated with pathological stage(P < 0.05) but not correlated with clinical stage (P > 0.05) in prostate cancer patients. FPSAR was significantly correlated with pathological stage and negatively correlated with clinical stage in prostate cancer patients (P < 0.05).</p><p><b>CONCLUSIONS</b>FPSAR is a more powerful predictor of clinical stage, pathological stage and prognosis than PSA.</p>
Asunto(s)
Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Patología / Neoplasias de la Próstata / Sangre / Antígeno Prostático Específico / Estadificación de Neoplasias Límite: Adulto / Anciano / Aged80 / Humanos / Masculino Idioma: Chino Revista: National Journal of Andrology Año: 2002 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Patología / Neoplasias de la Próstata / Sangre / Antígeno Prostático Específico / Estadificación de Neoplasias Límite: Adulto / Anciano / Aged80 / Humanos / Masculino Idioma: Chino Revista: National Journal of Andrology Año: 2002 Tipo del documento: Artículo